Omalizumab affects systemic levels of ceruloplasmin oxidase activity in severe allergic asthma

Didem A. Y., GÜMÜŞLÜ S., Parlak G., Sengul A., Gorczynski R.

31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Geneva, Switzerland, 16 - 20 June 2012, vol.67, pp.179 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 67
  • City: Geneva
  • Country: Switzerland
  • Page Numbers: pp.179
  • Akdeniz University Affiliated: Yes